Correlation Between Opthea and Aileron Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Opthea and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opthea and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Opthea and Aileron Therapeutics, you can compare the effects of market volatilities on Opthea and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opthea with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opthea and Aileron Therapeutics.

Diversification Opportunities for Opthea and Aileron Therapeutics

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Opthea and Aileron is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Opthea and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and Opthea is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opthea are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of Opthea i.e., Opthea and Aileron Therapeutics go up and down completely randomly.

Pair Corralation between Opthea and Aileron Therapeutics

Considering the 90-day investment horizon Opthea is expected to generate 0.88 times more return on investment than Aileron Therapeutics. However, Opthea is 1.14 times less risky than Aileron Therapeutics. It trades about -0.16 of its potential returns per unit of risk. Aileron Therapeutics is currently generating about -0.33 per unit of risk. If you would invest  436.00  in Opthea on September 1, 2024 and sell it today you would lose (67.00) from holding Opthea or give up 15.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Opthea  vs.  Aileron Therapeutics

 Performance 
       Timeline  
Opthea 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Opthea are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Opthea unveiled solid returns over the last few months and may actually be approaching a breakup point.
Aileron Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Aileron Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Aileron Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Opthea and Aileron Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Opthea and Aileron Therapeutics

The main advantage of trading using opposite Opthea and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opthea position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.
The idea behind Opthea and Aileron Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules